肾性贫血的治疗研究

Treatment of renal anemia

贫血是慢性肾脏病患者常见并发症,与患者肾脏疾病进展、远期生存、心血管不良事件等均有关。目前有许多新药可应用于临床治疗,包括低氧诱导因子脯氨酰羟化酶抑制剂、新型静脉铁剂、长效红细胞生成素等,可有效纠正贫血。本文综述了肾性贫血的治疗进展,为肾性贫血管理提供循证依据。

Anemia is a common complication and is related to progression of the kidney disease,longterm survival and adverse cardiovascular events in chronic kidney disease patients.Many new drugs can be clinically used to treat the anemia,including hypoxia-inducible factor prolyl hydroxylase inhibitors,new intravenous iron reagents,long-acting erythropoietin,etc.This article summarizes the progresses in the treatment of renal anemia so as to provide the evidence-based methods for clinical management of renal anemia.